Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion

Abstract Background Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. FRG1 which affects angiogenesis...

Full description

Bibliographic Details
Main Authors: Ankit Tiwari, Bratati Mukherjee, Md. Khurshidul Hassan, Niharika Pattanaik, Archita Mohanty Jaiswal, Manjusha Dixit
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-019-5509-4
_version_ 1811198571485069312
author Ankit Tiwari
Bratati Mukherjee
Md. Khurshidul Hassan
Niharika Pattanaik
Archita Mohanty Jaiswal
Manjusha Dixit
author_facet Ankit Tiwari
Bratati Mukherjee
Md. Khurshidul Hassan
Niharika Pattanaik
Archita Mohanty Jaiswal
Manjusha Dixit
author_sort Ankit Tiwari
collection DOAJ
description Abstract Background Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. FRG1 which affects angiogenesis and cell migration in Xenopus, can be a potential player in tumorigenesis. In this study, we investigated the role of FRG1 in prostate cancer progression. Methods Immunohistochemistry was performed to determine FRG1 expression in patient samples. FRG1 expression perturbation was done to investigate the effect of FRG1 on cell proliferation, migration and invasion, in DU145, PC3 and LNCaP cells. To understand the mechanism, we checked expression of various cytokines and MMPs by q-RT PCR, signaling molecules by western blot, in FRG1 perturbation sets. Results were validated by use of pharmacological inhibitor and activator and, western blot. Results In prostate cancer tissue, FRG1 levels were significantly reduced, compared to the uninvolved counterpart. FRG1 expression showed variable effect on PC3 and DU145 cell proliferation. FRG1 levels consistently affected cell migration and invasion, in both DU145 and PC3 cells. Ectopic expression of FRG1 led to significant reduction in cell migration and invasion in both DU145 and PC3 cells, reverse trends were observed with FRG1 knockdown. In androgen receptor positive cell line LNCaP, FRG1 doesn’t affect any of the cell properties. FRG1 knockdown led to significantly enhanced expression of GM-CSF, MMP1, PDGFA and CXCL1, in PC3 cells and, in DU145, it led to higher expression of GM-CSF, MMP1 and PLGF. Interestingly, FRG1 knockdown in both the cell lines led to activation of p38 MAPK. Pharmacological activation of p38 MAPK led to increase in the expression of GM-CSF and PLGF in DU145 whereas in PC3 it led to enhanced expression of GM-CSF, MMP1 and CXCL1. On the other hand, inhibition of p38 MAPK led to reduction in the expression of above mentioned cytokines. Conclusion FRG1 expression is reduced in prostate adenocarcinoma tissue. FRG1 expression affects migration and invasion in AR negative prostate cancer cells through known MMPs and cytokines, which may be mediated primarily via p38 MAPK activation.
first_indexed 2024-04-12T01:33:47Z
format Article
id doaj.art-302abd85fc4446449225d399de40da11
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-12T01:33:47Z
publishDate 2019-04-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-302abd85fc4446449225d399de40da112022-12-22T03:53:23ZengBMCBMC Cancer1471-24072019-04-0119111510.1186/s12885-019-5509-4Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasionAnkit Tiwari0Bratati Mukherjee1Md. Khurshidul Hassan2Niharika Pattanaik3Archita Mohanty Jaiswal4Manjusha Dixit5School of Biological Sciences, National Institute of Science Education and Research BhubaneswarSchool of Biological Sciences, National Institute of Science Education and Research BhubaneswarSchool of Biological Sciences, National Institute of Science Education and Research BhubaneswarSRL Diagnostics LtdSRL Diagnostics LtdSchool of Biological Sciences, National Institute of Science Education and Research BhubaneswarAbstract Background Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. FRG1 which affects angiogenesis and cell migration in Xenopus, can be a potential player in tumorigenesis. In this study, we investigated the role of FRG1 in prostate cancer progression. Methods Immunohistochemistry was performed to determine FRG1 expression in patient samples. FRG1 expression perturbation was done to investigate the effect of FRG1 on cell proliferation, migration and invasion, in DU145, PC3 and LNCaP cells. To understand the mechanism, we checked expression of various cytokines and MMPs by q-RT PCR, signaling molecules by western blot, in FRG1 perturbation sets. Results were validated by use of pharmacological inhibitor and activator and, western blot. Results In prostate cancer tissue, FRG1 levels were significantly reduced, compared to the uninvolved counterpart. FRG1 expression showed variable effect on PC3 and DU145 cell proliferation. FRG1 levels consistently affected cell migration and invasion, in both DU145 and PC3 cells. Ectopic expression of FRG1 led to significant reduction in cell migration and invasion in both DU145 and PC3 cells, reverse trends were observed with FRG1 knockdown. In androgen receptor positive cell line LNCaP, FRG1 doesn’t affect any of the cell properties. FRG1 knockdown led to significantly enhanced expression of GM-CSF, MMP1, PDGFA and CXCL1, in PC3 cells and, in DU145, it led to higher expression of GM-CSF, MMP1 and PLGF. Interestingly, FRG1 knockdown in both the cell lines led to activation of p38 MAPK. Pharmacological activation of p38 MAPK led to increase in the expression of GM-CSF and PLGF in DU145 whereas in PC3 it led to enhanced expression of GM-CSF, MMP1 and CXCL1. On the other hand, inhibition of p38 MAPK led to reduction in the expression of above mentioned cytokines. Conclusion FRG1 expression is reduced in prostate adenocarcinoma tissue. FRG1 expression affects migration and invasion in AR negative prostate cancer cells through known MMPs and cytokines, which may be mediated primarily via p38 MAPK activation.http://link.springer.com/article/10.1186/s12885-019-5509-4FRG1Prostate cancerImmunohistochemistryCell migrationCell invasionp38 MAPK
spellingShingle Ankit Tiwari
Bratati Mukherjee
Md. Khurshidul Hassan
Niharika Pattanaik
Archita Mohanty Jaiswal
Manjusha Dixit
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
BMC Cancer
FRG1
Prostate cancer
Immunohistochemistry
Cell migration
Cell invasion
p38 MAPK
title Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
title_full Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
title_fullStr Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
title_full_unstemmed Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
title_short Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
title_sort reduced frg1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
topic FRG1
Prostate cancer
Immunohistochemistry
Cell migration
Cell invasion
p38 MAPK
url http://link.springer.com/article/10.1186/s12885-019-5509-4
work_keys_str_mv AT ankittiwari reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion
AT bratatimukherjee reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion
AT mdkhurshidulhassan reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion
AT niharikapattanaik reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion
AT architamohantyjaiswal reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion
AT manjushadixit reducedfrg1expressionpromotesprostatecancerprogressionandaffectsprostatecancercellmigrationandinvasion